Wall Street Experts
ver. ZuMIgo(08/25)
Beam Therapeutics Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 350
EBIT TTM (mln): -183
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
52 |
61 |
378 |
64 |
Przychód Δ r/r |
0.0% |
0.0% |
inf% |
33.3% |
215916.7% |
17.5% |
520.0% |
-83.2% |
Marża brutto |
0.0% |
0.0% |
-29938.9% |
-429812.5% |
68.3% |
62.9% |
94.7% |
100.0% |
EBIT (mln) |
-8 |
-46 |
-75 |
-133 |
-392 |
-338 |
-176 |
-416 |
EBIT Δ r/r |
0.0% |
480.5% |
64.3% |
76.7% |
195.6% |
-13.8% |
-47.9% |
135.5% |
EBIT (%) |
0.0% |
0.0% |
-417522.2% |
-553166.7% |
-757.0% |
-555.6% |
-46.7% |
-654.3% |
Koszty finansowe (mln) |
0 |
0 |
0 |
2 |
-0 |
15 |
47 |
0 |
EBITDA (mln) |
-7 |
16 |
-69 |
-65 |
-414 |
-401 |
-156 |
-416 |
EBITDA(%) |
0.0% |
0.0% |
-384644.4% |
-269270.8% |
-799.1% |
-659.0% |
-41.4% |
-654.3% |
Podatek (mln) |
0 |
-71 |
0 |
62 |
-29 |
3 |
1 |
0 |
Zysk Netto (mln) |
-8 |
-115 |
-78 |
-256 |
-341 |
-264 |
-133 |
-377 |
Zysk netto Δ r/r |
0.0% |
1340.4% |
-31.9% |
226.9% |
33.1% |
-22.8% |
-49.7% |
184.3% |
Zysk netto (%) |
0.0% |
0.0% |
-435788.9% |
-1068433.3% |
-658.4% |
-432.7% |
-35.1% |
-593.1% |
EPS |
-0.62 |
-3.28 |
-1.53 |
-5.49 |
-5.31 |
-3.76 |
-1.72 |
-4.58 |
EPS (rozwodnione) |
-0.62 |
-3.28 |
-1.53 |
-5.49 |
-5.31 |
-3.76 |
-1.72 |
-4.58 |
Ilośc akcji (mln) |
13 |
35 |
51 |
47 |
64 |
70 |
77 |
82 |
Ważona ilośc akcji (mln) |
13 |
35 |
51 |
47 |
64 |
70 |
77 |
82 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |